Variables associated with endogenous hyperinsulinism in hypoglycemia diagnosis. Could the 72-hour fasting test be shortened in low-risk patients?

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina
dc.contributor.authorGonzález Vidal, Tomás
dc.contributor.authorGude Sampedro, Francisco
dc.contributor.authorMenéndez-Torre, Edelmiro
dc.date.accessioned2026-04-15T12:05:28Z
dc.date.available2026-04-15T12:05:28Z
dc.date.issued2025-06-01
dc.date.updated2026-03-27T12:40:32Z
dc.description.abstractBackground: The 72-hour fasting test remains the standard for the diagnosis of endogenous hyperinsulinism. We investigated which variables could identify patients at low risk for endogenous hyperinsulinism, in whom a shortening of the 72-hour fasting test could be considered. Methods: This multicenter, retrospective study included 64 individuals (46 women, median age 45 years) without diabetes who underwent 72-hour fasting tests for the etiologic diagnosis of hypoglycemia. Pre- and intra-test variables were collected, including point-of-care glucose trajectories during the test. Testing was stopped before 72 h if symptomatic serum glucose <55 mg/dL or asymptomatic serum glucose ≤45 mg/dL occurred. Endogenous hyperinsulinism was diagnosed in individuals who had serum glucose <55 mg/dL, serum insulin ≥3.0 μU/mL, and serum C-peptide ≥0.6 ng/mL. Results: Patients with endogenous hyperinsulinism (n = 10) had steeper descending point-of-care glucose trajectories (p < 0.001) than those without it. Older age and lower minimum pre-test serum glucose concentrations were independently associated with endogenous hyperinsulinism. A calculator for probability prediction of endogenous hyperinsulinism was developed including these variables and sex (AUC = 0.94). Older age, female sex, lower body mass index, and lower minimum point-of-care glucose during the first 24 h of fasting were independently associated with serum glucose <55 mg/dL after the first 24 h of fasting. A calculator for predicting probability of serum glucose <55 mg/dL after the first 24 h of fasting was developed including these variables (AUC = 0.84). Conclusions: Pre- and intra-test variables can identify individuals at low risk for endogenous hyperinsulinism, in whom shortening the 72-hour fasting test could be considered.en
dc.description.peerreviewedSI
dc.description.sponsorshipÓLB was supported by ISCIII Support Platforms for Clinical Research (ISCIII/PT23/00118/Co-funded by European Union). This research did not receive any other specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
dc.identifier.citationGonzález-Vidal, T., Lado-Baleato, Ó., Masid, I., Gándara-Gutiérrez, C., Martínez-Tamés, G., Ares, J., Lambert, C., Riestra-Fernández, M., Gude, F., Delgado, E., & Menéndez-Torre, E. (2025). Variables associated with endogenous hyperinsulinism in hypoglycemia diagnosis. Could the 72-hour fasting test be shortened in low-risk patients? Journal of Clinical and Translational Endocrinology, 40. https://doi.org/10.1016/J.JCTE.2025.100386
dc.identifier.doi10.1016/J.JCTE.2025.100386
dc.identifier.eissn2214-6237
dc.identifier.essn2214-6237
dc.identifier.urihttps://hdl.handle.net/10347/46720
dc.journal.titleJournal of Clinical and Translational Endocrinology
dc.language.isoeng
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/ISCIII/PT23/00118/EU
dc.relation.publisherversionhttps://doi.org/10.1016/j.jcte.2025.100386
dc.rights© 2025 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceJournal of Clinical and Translational Endocrinology
dc.subjectEndogenous hyperinsulinism
dc.subjectFasting test
dc.subjectHypoglycemia
dc.subjectInsulinoma
dc.titleVariables associated with endogenous hyperinsulinism in hypoglycemia diagnosis. Could the 72-hour fasting test be shortened in low-risk patients?en
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number40
dspace.entity.typePublication
oaire.awardNumberISCIII/PT23/00118
oaire.funderIdentifier10.13039/501100000780
oaire.funderNameEuropean Commission
oaire.funderNameISCIII Support Platforms for Clinical Research
relation.isAuthorOfPublication61ef7bd7-5fc0-4694-82ef-d102c16b2204
relation.isAuthorOfPublication.latestForDiscovery61ef7bd7-5fc0-4694-82ef-d102c16b2204

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2025_jcte_gude_variables.pdf
Size:
1.85 MB
Format:
Adobe Portable Document Format